The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,166.00
Bid: 1,167.00
Ask: 1,171.00
Change: -4.00 (-0.34%)
Spread: 4.00 (0.343%)
Open: 1,171.00
High: 1,175.00
Low: 1,149.00
Prev. Close: 1,170.00
HSX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Announcement of share repurchase programme

5 Mar 2024 07:01

RNS Number : 5484F
Hiscox Ltd
05 March 2024
 

 

Announcement of share repurchase programme

 

Hamilton, Bermuda (5 March 2024) - Hiscox Ltd ("Hiscox" or the "Company") today announces it will commence a buyback of its ordinary shares of 6.5 pence each ("Ordinary Shares") for a maximum aggregate consideration of $150 million (the "Programme"), in order to return additional capital to shareholders. The Programme will commence today with an initial tranche of $75 million.

 

Hiscox has entered into a non-discretionary agreement with Peel Hunt LLP ("Peel Hunt") to conduct the initial tranche of the Programme with the Company subsequently purchasing its Ordinary Shares from Peel Hunt. Under this arrangement, Peel Hunt will act as principal and make trading decisions independently of Hiscox, except for Hiscox's ability to terminate Peel Hunt's mandate in certain limited circumstances.

 

The maximum aggregate consideration under the initial tranche is $75 million (excluding expenses). The Company intends to cancel such Ordinary Shares purchased. The sole purpose of the Programme is to reduce Hiscox's share capital.

 

Purchases under the Programme will take place in open market transactions and may be made from time to time by Peel Hunt, depending on market conditions, share price and trading volumes. The Programme will be effected under the authority granted by shareholders at the Company's 2023 Annual General Meeting held on 11 May 2023 (and any subsequent authority) and, as at the date of this announcement, the maximum number of shares that may be repurchased under the Programme is 34,655,073 Ordinary Shares. Any purchases contemplated by this announcement will be carried out on the London Stock Exchange and/or other recognised investment exchange(s). The Programme's initial tranche will end when the maximum aggregate consideration reaches $75 million or as otherwise terminated.

 

The Programme will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014 and the Commission Delegated Regulation (EU) 2016/1052 as it forms part of UK law pursuant to the UK's European Union (Withdrawal) Act 2018 and the Market Abuse (Amendment) (EU Exit) Regulations 2019) as well as applicable laws and the regulations of the UK Financial Conduct Authority (including Chapter 12 of the Listing Rules). Any repurchase of shares will be announced no later than 7:30 a.m. on the business day following the calendar day on which the repurchase occurred.

 

There is no guarantee that the Programme will be implemented in full.

 

The Company intends to enter into arrangements to commence a second tranche of the share buyback programme with Citigroup Global Markets Limited for a maximum aggregate consideration of $75 million in due course.

 

Aki Hussain, Group Chief Executive Officer, Hiscox Ltd, commented:

 

"Our business delivered record profits of $625.9 million and ROE of 21.8%[1] in 2023. This excellent result has led to very strong capital generation, which we are deploying for further growth in all parts of the business in addition to a special return to shareholders of $150 million. The buyback will commence immediately and illustrates our objective of delivering strong returns to our shareholders."

 

ENDS

 

 

For further information

Investors and analysts

Yana O'Sullivan, Director of Investor Relations, London +44 (0)20 3321 5598

Marc Wetherhill, Group Company Secretary, Bermuda +1 441 278 8300

 

Media

Eleanor Orebi Gann, Group Director of Communications, London +44 (0)20 7081 4815

Simone Selzer, Brunswick +44 (0)20 7404 5959

Tom Burns, Brunswick +44 (0)20 7404 5959

Notes to editors

About The Hiscox Group

Hiscox is a global specialist insurer, headquartered in Bermuda and listed on the London Stock Exchange (LSE:HSX). Our ambition is to be a respected specialist insurer with a diverse portfolio by product and geography. We believe that building balance between catastrophe-exposed business and less volatile local specialty business gives us opportunities for profitable growth throughout the insurance cycle. 

The Hiscox Group employs over 3,000 people in 14 countries, and has customers worldwide. Through the retail businesses in the USA, UK, Europe and Asia, we offer a range of specialist insurance products in commercial and personal lines. Internationally-traded, bigger-ticket business and reinsurance is underwritten through Hiscox London Market and Hiscox Re & ILS.

Our values define our business, with a focus on people, courage, ownership and integrity. We pride ourselves on being true to our word and our award-winning claims service is testament to that. For more information, visit www.hiscoxgroup.com.

 


[1]Excludes impact of Bermuda Deferred Tax Asset.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSQKQBDBBKBDNK
Date   Source Headline
2nd Mar 20207:01 amRNSHiscox Ltd full year results
6th Jan 202010:06 amRNSTR-1: Standard form-notification of major holdings
2nd Jan 20201:13 pmRNSTotal Voting Rights
17th Dec 20192:33 pmRNSNotification of transactions
2nd Dec 20191:15 pmRNSTotal Voting Rights
13th Nov 20197:00 amRNSDirector/PDMR Shareholding
11th Nov 20195:12 pmRNSTR-1: Standard form-notification of major holdings
7th Nov 20192:08 pmRNSHiscox Ltd market announcement
4th Nov 20197:01 amRNSHiscox Ltd Q3 Trading Statement
4th Nov 20197:00 amRNSSyndicates 33 and 6104 - estimates
1st Nov 20193:27 pmRNSTotal Voting Rights
1st Oct 20194:39 pmRNSDirector/PDMR Shareholding
1st Oct 20194:30 pmRNSTotal Voting Rights
20th Sep 20192:35 pmRNSDirector/PDMR Shareholding
18th Sep 20194:18 pmRNS2020 Syndicate Business Forecast
17th Sep 20195:35 pmRNSDirector/PDMR Shareholding
13th Sep 20195:16 pmRNSDirector/PDMR Shareholding
9th Sep 20191:15 pmRNSApplication to be Admitted to Official List
5th Sep 20197:00 amRNSAppointment of Group Chief Underwriting Officer
3rd Sep 20192:40 pmRNSTotal Voting Rights
27th Aug 20194:06 pmRNSAnnouncement of Scrip Reference Share Price
20th Aug 20193:35 pmRNSDirector/PDMR Shareholding
19th Aug 20195:28 pmRNSTR-1: Standard form-notification of major holdings
7th Aug 20191:21 pmRNSDirector/PDMR Shareholding
2nd Aug 201911:40 amRNSTotal Voting Rights
1st Aug 20192:33 pmRNSApplication for Block Listing
1st Aug 20197:00 amRNSDirector/PDMR Shareholding
29th Jul 20197:01 amRNSHiscox Ltd interim results
29th Jul 20197:00 amRNSSyndicates 33 and 6104 - estimates
17th Jul 20191:37 pmRNSTR-1: Standard form-notification of major holdings
12th Jul 20197:00 amRNSTrading update
1st Jul 20194:53 pmRNSTotal Voting Rights
27th Jun 20197:00 amRNSRichard Watson - Retirement
18th Jun 20194:22 pmRNSDirector/PDMR Shareholding
18th Jun 20194:22 pmRNSDirector/PDMR Shareholding
10th Jun 20192:45 pmRNSApplication to be Admitted to Official List
3rd Jun 20191:51 pmRNSTotal Voting Rights
30th May 20193:29 pmRNSAnnouncement of Scrip Reference Share Price
23rd May 20194:55 pmRNSDirector/PDMR Shareholding
16th May 20196:28 pmRNSEGM Results
16th May 20196:28 pmRNSResult of AGM
15th May 20193:06 pmRNSBLOCK LISTING SIX MONTHLY RETURN
10th May 201912:21 pmRNSDirector/PDMR Shareholding
7th May 20197:01 amRNSHiscox Ltd Q1 Trading Statement
7th May 20197:00 amRNSSyndicates 33 and 6104 - estimates
1st May 20193:43 pmRNSTotal Voting Rights
30th Apr 20193:13 pmRNSNotice of 2019 Extraordinary General Meeting
11th Apr 20197:00 amRNSDirector/PDMR Shareholding
11th Apr 20197:00 amRNSDirector/PDMR Shareholding
11th Apr 20197:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.